- Biotech funding optimism rises as 44% predict recovery in 2024 Pharmaceutical Technology
- Biotech continues to demonstrate dependable growth with a cyclical boost FE Trustnet
- Neuroscience renaissance leads to new crop of psychiatric drugs STAT
- Biotech Stocks Are on a Tear. They Could Keep Climbing. Barron’s
- Resilience amidst uncertainty in biotech: A Q&A with BB Biotech’s Dr Daniel Koller IFA Magazine
The wire
More investor news
Anthropic strikes $45bn deal with Nscale to rent compute capacity – Sifted
Redmi Note 17 Pro Max: Release date, price and specs – TechCabal
Kenya’s EV push gets boost as NCBA, BasiGo seal financing deal for 1,000 vehicles – TechCabal
Sony Xperia 10 VIII: Release date, price and specs – TechCabal
Nvidia strikes $12.9bn deal for Hugging Face, reports say – Sifted
Sweden’s top-funded tech companies in H1 2026 – Tech.eu